open access

Vol 82, No 4 (2014)
ORIGINAL PAPERS
Submitted: 2014-06-25
Accepted: 2014-06-25
Get Citation

The quality of life of non-small cell lung cancer patients treated with chemotherapy

Bożenna Karczmarek-Borowska, Maria Pelc, Ewa Rabiej, Monika Grądalska-Lampart
DOI: 10.5603/PiAP.2014.0044
·
Pneumonol Alergol Pol 2014;82(4):349-357.

open access

Vol 82, No 4 (2014)
ORIGINAL PAPERS
Submitted: 2014-06-25
Accepted: 2014-06-25

Abstract

Introduction: The aim of the study was to assess the influence of non-small cell lung cancer chemotherapy on patients’ health status, the occurrence of adverse events and their effect on everyday activities, depending on the patients’ sex and age.

Material and methods: The study group consisted of 62 non-small cell lung cancer patients, (21 women and 41 men), aged 51–84 years, hospitalised due to the chemotherapy. The survey included SF-20 test and a questionnaire prepared by the authors.

Results: The most frequent adverse events indicated by the patients were: weakness (79%), nausea and vomiting (77%), loss of appetite (56%) and diarrhoea (45%). It was found that the side-effects of chemotherapy were not dependent on age (p = 0.9882) or sex (p = 0.9968). The chemotherapy negatively influenced the quality of the patients’ life (p < 0.000001). It was shown that there is a statistically significant correlation between age and limitations on social roles, professional life and performing housework (p < 0.0133), and also the inability to perform specific types of activities (p < 0.01).

Conclusions: The results of the study show that chemotherapy of non-small cell lung cancer was connected with decreased quality of life, especially in patients over 65 years of age. The patients under 65 years of age could not deal with the disease in respect of psychological aspects, whereas people over 65 years of age had greater problems with physical, social and professional functioning.

Abstract

Introduction: The aim of the study was to assess the influence of non-small cell lung cancer chemotherapy on patients’ health status, the occurrence of adverse events and their effect on everyday activities, depending on the patients’ sex and age.

Material and methods: The study group consisted of 62 non-small cell lung cancer patients, (21 women and 41 men), aged 51–84 years, hospitalised due to the chemotherapy. The survey included SF-20 test and a questionnaire prepared by the authors.

Results: The most frequent adverse events indicated by the patients were: weakness (79%), nausea and vomiting (77%), loss of appetite (56%) and diarrhoea (45%). It was found that the side-effects of chemotherapy were not dependent on age (p = 0.9882) or sex (p = 0.9968). The chemotherapy negatively influenced the quality of the patients’ life (p < 0.000001). It was shown that there is a statistically significant correlation between age and limitations on social roles, professional life and performing housework (p < 0.0133), and also the inability to perform specific types of activities (p < 0.01).

Conclusions: The results of the study show that chemotherapy of non-small cell lung cancer was connected with decreased quality of life, especially in patients over 65 years of age. The patients under 65 years of age could not deal with the disease in respect of psychological aspects, whereas people over 65 years of age had greater problems with physical, social and professional functioning.

Get Citation

Keywords

chemotherapy, quality of life, non-small cell lung cancer, adverse events

About this article
Title

The quality of life of non-small cell lung cancer patients treated with chemotherapy

Journal

Advances in Respiratory Medicine

Issue

Vol 82, No 4 (2014)

Pages

349-357

DOI

10.5603/PiAP.2014.0044

Bibliographic record

Pneumonol Alergol Pol 2014;82(4):349-357.

Keywords

chemotherapy
quality of life
non-small cell lung cancer
adverse events

Authors

Bożenna Karczmarek-Borowska
Maria Pelc
Ewa Rabiej
Monika Grądalska-Lampart

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl